Related Experiment Video

Updated: Jul 19, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis

Nada Brncić1, Ivan Kraus, Ivica Visković

  • 1Department of Infectious Diseases, University Hospital Center, Rijeka, Croatia. nada.brncic@medri.hr

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|October 31, 2006
PubMed
Abstract

Insights

3,4-methylenedioxymethamphetamine (MDMA) can cause liver damage, ranging from mild to severe. This case study highlights a young male

Area of Science:

  • Toxicology
  • Hepatology
  • Pharmacology

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA), known as "Ecstasy," is associated with potential hepatotoxicity.
  • MDMA-induced liver injury presents with variable clinical manifestations, from asymptomatic elevations in liver enzymes to acute liver failure.
  • Predictive factors for MDMA hepatotoxicity outcomes are currently unknown.

Observation:

  • A 19-year-old male developed jaundice two weeks post-Ecstasy ingestion.
  • Clinical presentation, lab results, and morphology indicated acute hepatitis.
  • Viral, alcoholic, metabolic, and autoimmune causes were excluded.

Findings:

  • The patient experienced a mild clinical course with full recovery within two months.
  • MDMA (3,4-methylenedioxymethamphetamine) was confirmed in the patient's system.
  • No other etiology for the hepatitis was identified.

Implications:

  • This case suggests a potential link between MDMA use and acute hepatitis.
  • Further research is warranted to explore the association between specific human leukocyte antigen (HLA) phenotypes and MDMA-induced hepatotoxicity.
  • Understanding these associations may aid in predicting patient outcomes and developing targeted interventions.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...